Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
United Therapeutics Corporation (UTHR) had Weighted-Average Shares Outstanding (Diluted) of 47.20M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$781.50M |
|
$274.90M |
|
$133.40M |
|
$648.10M |
|
$455.70M |
|
$325.80M |
|
$-7.50M |
|
$318.30M |
|
$318.30M |
|
$274.90M |
|
$274.90M |
|
$274.90M |
|
$274.90M |
|
$325.80M |
|
$348.40M |
|
43.50M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
47.20M |
$6.32 |
|
$5.82 |
|
| Balance Sheet Financials | |
$2.87B |
|
$1.84B |
|
$3.84B |
|
$6.71B |
|
$599.10M |
|
-- |
|
$214.00M |
|
$813.10M |
|
$5.90B |
|
$5.79B |
|
$5.90B |
|
42.16M |
|
| Cash Flow Statement Financials | |
$463.30M |
|
$743.70M |
|
$-1.48B |
|
$1.56B |
|
$1.28B |
|
$-277.40M |
|
$33.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
82.93% |
|
41.69% |
|
41.69% |
|
-- |
|
40.73% |
|
35.18% |
|
$362.50M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.75 |
|
2.50 |
|
35.93 |
|
4.66% |
|
4.75% |
|
4.09% |
|
4.66% |
|
$139.98 |
|
$7.68 |
|
$9.82 |
|